Exeantide in Type 2 Diabetes on Insulin

NCT01154933 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: exenatide 5 mcg
DRUG: exenatide 10 mcg
DRUG: placebo

Sponsor

University at Buffalo

Collaborators

[object Object]